BCL2 and gastric cancer: suggested that SIT-dependent activation of p-extracellular signal-regulated kinase (ERK)1/2 and Bcl-2 can enhance the activity of human monocytes and strengthen their ability to kill gastric cancer SGC-7901 cells (23).